A cease trade order (CTO) was issued by
the Ontario Securities Commission on Aug. 20, 2024, due to Medicine Man Technologies Inc.'s
failure to file the following periodic disclosure:
- Interim financial statements for the period ended March 31, 2024;
- Management's discussion and analysis relating to the interim financial statements for the
period ended March 31, 2024;
- Interim financial statements for the period ended June 30, 2024;
- Management's discussion and analysis relating to the interim financial statements for the
period ended June 30, 2024;
- Certification of the foregoing filings as required by National Instrument 52-109,
Certification of Disclosure in Issuers' Annual and Interim Filings.
The common shares of Medicine Man have been suspended pursuant to the CTO.
© 2025 Canjex Publishing Ltd. All rights reserved.